Cargando…

Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients

PURPOSE: Adjuvant chemotherapy (AC) is recommended for patients with stage II colorectal cancer with adverse features. However, the effect of adjuvant treatment in elderly patients with high-risk stage II colorectal cancer remains controversial. This study aimed to investigate the oncologic outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yujin, Park, Inseok, Cho, Hyunjin, Gwak, Geumhee, Yang, Keunho, Bae, Byung-Noe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Coloproctology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566145/ https://www.ncbi.nlm.nih.gov/pubmed/34228912 http://dx.doi.org/10.3393/ac.2020.00829.0118

Ejemplares similares

Prognostic Factors Affecting Disease-Free Survival and Overall Survival in T4 Colon Cancer
por: Eom, Taeyeong, et al.
Publicado: (2021)

Perioperative Serum Carcinoembryonic Antigen Ratio Is a Prognostic Indicator in Patients With Stage II Colorectal Cancer
por: Woo, Jinsun, et al.
Publicado: (2018)

Prognostic Factors and Management for Left Colonic Perforation: Can Hartmann’s Procedure Be Preventable?
por: Joo, Yilseok, et al.
Publicado: (2020)

Scoring System for Differentiation of Complicated Appendicitis in Pediatric Patients: Appendicitis Scoring System in Children
por: Lee, Yujin, et al.
Publicado: (2021)

Preoperative predictive factors for gallbladder cholesterol polyp diagnosed after laparoscopic cholecystectomy for polypoid lesions of gallbladder
por: Lee, Hyojin, et al.
Publicado: (2016)

Risk Factors of a Pulmonary Thromboembolism After Colorectal Surgery
por: Kim, Junyub, et al.
Publicado: (2015)

Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
por: Park, Chansub, et al.
Publicado: (2016)

Comparative Study of a Single-Incision Laparoscopic and a Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
por: Kang, Jungwoo, et al.
Publicado: (2012)

Unmodifiable Clinicopathological Risk Factors of Shoulder Tip or Subcostal Pain after Laparoscopic Appendectomy
por: Kim, Bomi, et al.
Publicado: (2020)

Comparison of Compliance of Adjuvant Chemotherapy Between Laparoscopic and Open Surgery in Patients With Colon Cancer
por: Chun, Kan Ho, et al.
Publicado: (2014)

Predictive Factors Affecting the Clinical Course of Patients With Diverticulitis: Who Needs Hospital Management?
por: Yoo, Taeyoung, et al.
Publicado: (2018)

The increased risk of colorectal cancer in the women who underwent hysterectomy from the South Korean National Health Insurance Database
por: Yuk, Jin -Sung, et al.
Publicado: (2023)

Analysis of the Potent Prognostic Factors in Luminal-Type Breast Cancer
por: Kim, Han-Sung, et al.
Publicado: (2012)

Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
por: Gwak, Geumhee, et al.
Publicado: (2011)

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients
por: Woo, Jinsun, et al.
Publicado: (2021)

Association between breast diseases and symptomatic uterine fibroids by using South Korean National Health Insurance database
por: Yuk, Jin-Sung, et al.
Publicado: (2023)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
por: Glimelius, Bengt, et al.
Publicado: (2020)

The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
por: Hayashi, Naomi, et al.
Publicado: (2020)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
por: Guo, Jianping, et al.
Publicado: (2023)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
por: Kim, Jung Ho, et al.
Publicado: (2015)

Differences in prognosis and underuse of adjuvant chemotherapy between elderly and non‐elderly patients in stage III colorectal cancer
por: Shiraishi, Takuya, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

Immunological nomograms predicting prognosis and guiding adjuvant chemotherapy in stage II colorectal cancer
por: Feng, Yang, et al.
Publicado: (2019)

The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma
por: Zhao, Zhuang, et al.
Publicado: (2020)

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
por: Kwon, Yujin, et al.
Publicado: (2017)

Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer
por: Iveson, Timothy J., et al.
Publicado: (2021)

Prognostic Significance of a Micropapillary Pattern in Pure Mucinous Carcinoma of the Breast: Comparative Analysis with Micropapillary Carcinoma
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Predictive Models of Adjuvant Chemotherapy for Patients with Stage II Colorectal Cancer: A Retrospective Study
por: Wei, Bo, et al.
Publicado: (2017)

Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective study
por: Jalaeikhoo, Hasan, et al.
Publicado: (2019)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
por: Chen, Yuanyuan, et al.
Publicado: (2022)

Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy
por: Liang, Lei, et al.
Publicado: (2015)

Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer
por: Cho, Jung Rae, et al.
Publicado: (2022)

Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II
por: Horvat, Matej, et al.
Publicado: (2016)

The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
por: Min, Byung-Hoon, et al.
Publicado: (2011)

Recent trends in use of adjuvant chemotherapy in elderly stage II–III non-small cell lung cancer
por: Komiya, Takefumi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ve7lrut958lnlvu6u08vgkp5n